NO905373L - Fremgangsmaate for fremstilling av nye fosfolipid-derivater - Google Patents

Fremgangsmaate for fremstilling av nye fosfolipid-derivater

Info

Publication number
NO905373L
NO905373L NO90905373A NO905373A NO905373L NO 905373 L NO905373 L NO 905373L NO 90905373 A NO90905373 A NO 90905373A NO 905373 A NO905373 A NO 905373A NO 905373 L NO905373 L NO 905373L
Authority
NO
Norway
Prior art keywords
procedure
preparation
phospholipid derivatives
new phospholipid
new
Prior art date
Application number
NO90905373A
Other languages
English (en)
Other versions
NO905373D0 (no
NO177146B (no
NO177146C (no
Inventor
Pierre Braquet
Colette Broquet
Benedicte Vandamme
Paola Principe-Nicolas
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of NO905373D0 publication Critical patent/NO905373D0/no
Publication of NO905373L publication Critical patent/NO905373L/no
Publication of NO177146B publication Critical patent/NO177146B/no
Publication of NO177146C publication Critical patent/NO177146C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/10Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20Quaternary compounds thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
NO905373A 1989-12-19 1990-12-12 Analogifremgangsmåte for fremstilling av nye fosfolipid-derivater NO177146C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898928580A GB8928580D0 (en) 1989-12-19 1989-12-19 3-(n-methyl-n-alkylamino)-methoxymethyl-propanol phosphocholine derivatives

Publications (4)

Publication Number Publication Date
NO905373D0 NO905373D0 (no) 1990-12-12
NO905373L true NO905373L (no) 1991-06-20
NO177146B NO177146B (no) 1995-04-18
NO177146C NO177146C (no) 1995-07-26

Family

ID=10668132

Family Applications (1)

Application Number Title Priority Date Filing Date
NO905373A NO177146C (no) 1989-12-19 1990-12-12 Analogifremgangsmåte for fremstilling av nye fosfolipid-derivater

Country Status (32)

Country Link
US (1) US5118674A (no)
JP (1) JPH04208256A (no)
KR (1) KR910011759A (no)
AR (1) AR246742A1 (no)
AT (1) AT400333B (no)
AU (1) AU630056B2 (no)
BE (1) BE1004089A3 (no)
CA (1) CA2032224C (no)
CH (1) CH681624A5 (no)
DE (1) DE4040685A1 (no)
DK (1) DK171298B1 (no)
DZ (1) DZ1471A1 (no)
ES (1) ES2023607A6 (no)
FI (1) FI906162A (no)
FR (2) FR2656307B1 (no)
GB (2) GB8928580D0 (no)
GR (1) GR1000893B (no)
HK (1) HK118093A (no)
IE (1) IE65888B1 (no)
IN (1) IN173969B (no)
IT (1) IT1243412B (no)
LU (1) LU87853A1 (no)
MA (1) MA22013A1 (no)
MY (1) MY104781A (no)
NL (1) NL9002582A (no)
NO (1) NO177146C (no)
NZ (1) NZ236213A (no)
OA (1) OA09475A (no)
PT (1) PT96265B (no)
SE (1) SE469383B (no)
TN (1) TNSN90152A1 (no)
ZA (1) ZA909663B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551623B1 (en) 1993-09-09 2003-04-22 Lorus Therapeutics Inc. Immunomodulating compositions from bile
WO1995007089A1 (en) 1993-09-09 1995-03-16 Imutec Corporation Immunomodulating compositions from bile
CN1182368A (zh) 1995-03-16 1998-05-20 伊姆特克药物公司 来源于胆汁的治疗免疫系统紊乱的免疫调节组合物
US20040101569A1 (en) * 1996-05-16 2004-05-27 Lorus Therapeutics Inc. Immunomodulating compositions from bile
DE19711758C2 (de) * 1997-03-21 2003-06-18 Degussa Verfahren zur Herstellung von 1,3-Dioxanverbindungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732263A1 (de) * 1977-07-16 1979-02-01 Schuler Gmbh L Vorrichtung zum herstellen einer sicke am umfang eines hohlzylinders
DE2820893C2 (de) * 1978-05-12 1986-02-20 A. Nattermann & Cie GmbH, 5000 Köln Strukturanaloga von natürlichen Phospholipiden und Verfahren zur Herstellung dieser Verbindungen
US4737518A (en) * 1984-04-03 1988-04-12 Takeda Chemical Industries, Ltd. Lipid derivatives, their production and use
WO1989007099A1 (en) * 1988-02-05 1989-08-10 Schering Corporation 2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use
JP2534893B2 (ja) * 1988-06-24 1996-09-18 日本ケミファ株式会社 新規なグリセリン誘導体およびその誘導体を含有する血小板凝集抑制剤
DE3906952A1 (de) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel
GR1000688B (el) * 1989-12-22 1992-10-08 Sod Conseils Rech Applic Μεθοδος παρασκευης παραγωγων γλυκερινης.

Also Published As

Publication number Publication date
FR2656797A1 (fr) 1991-07-12
FR2656797B1 (fr) 1992-09-18
GB2239239A (en) 1991-06-26
IE65888B1 (en) 1995-11-29
GB9027421D0 (en) 1991-02-06
AU6814290A (en) 1991-06-27
AT400333B (de) 1995-12-27
MY104781A (en) 1994-05-31
NZ236213A (en) 1993-03-26
GR900100812A (en) 1992-05-12
IT9022438A1 (it) 1992-06-19
GB8928580D0 (en) 1990-02-21
HK118093A (en) 1993-11-12
DK171298B1 (da) 1996-08-26
OA09475A (fr) 1992-11-15
PT96265B (pt) 1998-06-30
ZA909663B (en) 1991-09-25
CH681624A5 (no) 1993-04-30
SE469383B (sv) 1993-06-28
PT96265A (pt) 1991-09-30
FR2656307B1 (fr) 1992-09-18
DK299590D0 (da) 1990-12-18
DK299590A (da) 1991-06-20
FI906162A (fi) 1991-06-20
LU87853A1 (fr) 1991-05-07
FR2656307A1 (fr) 1991-06-28
CA2032224A1 (en) 1991-06-20
DE4040685A1 (de) 1991-06-20
NO905373D0 (no) 1990-12-12
FI906162A0 (fi) 1990-12-14
GR1000893B (el) 1993-03-16
NO177146B (no) 1995-04-18
CA2032224C (en) 1996-12-10
IE904567A1 (en) 1991-06-19
DZ1471A1 (fr) 2004-09-13
NL9002582A (nl) 1991-07-16
US5118674A (en) 1992-06-02
IN173969B (no) 1994-08-13
MA22013A1 (fr) 1991-07-01
IT9022438A0 (it) 1990-12-19
BE1004089A3 (fr) 1992-09-22
ES2023607A6 (es) 1992-01-16
KR910011759A (ko) 1991-08-07
AR246742A1 (es) 1994-09-30
SE9004039L (sv) 1991-06-20
TNSN90152A1 (fr) 1991-03-05
NO177146C (no) 1995-07-26
SE9004039D0 (sv) 1990-12-18
GB2239239B (en) 1993-06-02
JPH04208256A (ja) 1992-07-29
IT1243412B (it) 1994-06-10
AU630056B2 (en) 1992-10-15
ATA259590A (de) 1995-04-15

Similar Documents

Publication Publication Date Title
NO873091D0 (no) Fremgangsmaate for fremstilling av nye benzimidazolderivater.
NO891951D0 (no) Fremgangsmaate for fremstilling av nye hydroksamat-derivater.
NO174424C (no) Fremgangsmåte for fremstilling av dinatrium-cefodizim
NO904059L (no) Fremgangsmaate for fremstilling av nye substituerte isokinoliner.
FI95036B (fi) Tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä
NO844978L (no) Fremgangsmaate ved fremstilling av nye aminoguanidinderivater
NO171974C (no) Fremgangsmaate for fremstilling av nafthalenderivater
NO901813L (no) Fremgangsmaate for fremstilling av nye tieno-triazolo-diazepin-derivater.
NO903043L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO880294L (no) Fremgangsmaate for fremstilling av tetrahydrofuranderivater
NO892977L (no) Fremgangsmaate for fremstilling av nye s-adenosylmethionin-derivater.
NO901102L (no) Fremgangsmaate for fremstilling av nye steroidderivater.
NO905373D0 (no) Fremgangsmaate for fremstilling av nye fosfolipid-derivater
NO904069D0 (no) Fremgangsmaate for fremstilling av nye alkanofenoner.
NO872393D0 (no) Fremgangsmaate for fremstilling av nye aralkylimidazolderivater.
NO893006D0 (no) Fremgangsmaate for fremstilling av nye allylaminoetylazoler
NO871721L (no) Fremgangsmaate for fremstilling av nye ergolenderivater.
NO904588D0 (no) Fremgangsmaate til fremstilling av diazinylpiperidin-derivater
NO884901D0 (no) Fremgangsmaate for fremstilling av nye indenofuranderivater
NO872683D0 (no) Fremgangsmaate for fremstilling av difenylazometinderivater
NO911665L (no) Fremgangsmaate for fremstilling av nye nojirimycinderivater
NO902293D0 (no) Fremgangsmaate for fremstilling av nye tiazepinderivater.
NO851620L (no) Fremgangsmaate for fremstilling av nye bornan-derivater
NO934268L (no) Fremgangsmaate for fremstilling av 3-substituerte-2-oksindol-derivater
NO180301C (no) Fremgangsmåte for fremstilling av azaspiroalkanderivater